Display options
Share it on

Sci Rep. 2021 Nov 04;11(1):21688. doi: 10.1038/s41598-021-01226-1.

Corneal confocal microscopy demonstrates axonal loss in different courses of multiple sclerosis.

Scientific reports

Ioannis N Petropoulos, Kathryn C Fitzgerald, Jonathan Oakley, Georgios Ponirakis, Adnan Khan, Hoda Gad, Pooja George, Dirk Deleu, Beatriz G Canibano, Naveed Akhtar, Ashfaq Shuaib, Ahmed Own, Taimur Malik, Daniel B Russakoff, Joseph L Mankowski, Stuti L Misra, Charles N J McGhee, Peter Calabresi, Shiv Saidha, Saadat Kamran, Rayaz A Malik

Affiliations

  1. Research Division, Qatar Foundation, Weill Cornell Medicine-Qatar of Cornell University, PO Box 24144, Education City, Doha, Qatar.
  2. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  3. Voxeleron LLC, San Francisco, CA, USA.
  4. Neuroscience Institute, Hamad General Hospital, Doha, Qatar.
  5. Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  6. Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  7. Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.
  8. Research Division, Qatar Foundation, Weill Cornell Medicine-Qatar of Cornell University, PO Box 24144, Education City, Doha, Qatar. [email protected].

PMID: 34737384 PMCID: PMC8568943 DOI: 10.1038/s41598-021-01226-1

Abstract

Axonal loss is the main determinant of disease progression in multiple sclerosis (MS). This study aimed to assess the utility of corneal confocal microscopy (CCM) in detecting corneal axonal loss in different courses of MS. The results were confirmed by two independent segmentation methods. 72 subjects (144 eyes) [(clinically isolated syndrome (n = 9); relapsing-remitting MS (n = 20); secondary-progressive MS (n = 22); and age-matched, healthy controls (n = 21)] underwent CCM and assessment of their disability status. Two independent algorithms (ACCMetrics; and Voxeleron deepNerve) were used to quantify corneal nerve fiber density (CNFD) (ACCMetrics only), corneal nerve fiber length (CNFL) and corneal nerve fractal dimension (CNFrD). Data are expressed as mean ± standard deviation with 95% confidence interval (CI). Compared to controls, patients with MS had significantly lower CNFD (34.76 ± 5.57 vs. 19.85 ± 6.75 fibers/mm

© 2021. The Author(s).

References

  1. Stat Methods Med Res. 1999 Jun;8(2):135-60 - PubMed
  2. Comput Biol Med. 1989;19(1):61-70 - PubMed
  3. Ann Clin Transl Neurol. 2019 Mar 02;6(4):689-697 - PubMed
  4. Psychol Bull. 1979 Mar;86(2):420-8 - PubMed
  5. Neuropathol Appl Neurobiol. 2001 Jun;27(3):238-44 - PubMed
  6. Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):1113-1118 - PubMed
  7. Cytometry A. 2004 Apr;58(2):167-76 - PubMed
  8. Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO52-BIO60 - PubMed
  9. Transl Vis Sci Technol. 2021 Apr 1;10(4):19 - PubMed
  10. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5060-5 - PubMed
  11. Cornea. 2013 Oct;32(10):1331-8 - PubMed
  12. Diabetes Care. 2014 Sep;37(9):2643-6 - PubMed
  13. Brain. 1997 Mar;120 ( Pt 3):393-9 - PubMed
  14. Biometrics. 2018 Jun;74(2):595-605 - PubMed
  15. Med Image Anal. 2011 Oct;15(5):738-47 - PubMed
  16. Ann Clin Transl Neurol. 2015 Dec 28;3(2):88-100 - PubMed
  17. Diabetes Care. 2015 Jun;38(6):1138-44 - PubMed
  18. JAMA Ophthalmol. 2017 Jul 1;135(7):777-782 - PubMed
  19. Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3677-3681 - PubMed
  20. Ann Neurol. 2018 Dec;84(6):893-904 - PubMed
  21. Mult Scler. 2005 Jun;11(3):282-5 - PubMed
  22. Diabetes Care. 2015 Apr;38(4):671-5 - PubMed
  23. Cornea. 2020 Oct;39(10):1221-1226 - PubMed
  24. Diabetologia. 2019 Aug;62(8):1478-1487 - PubMed
  25. Mult Scler. 2017 Dec;23(14):1847-1853 - PubMed
  26. Diabetes. 2013 Jan;62(1):254-60 - PubMed
  27. Eye Vis (Lond). 2020 May 8;7:27 - PubMed
  28. Ann Neurol. 2011 Feb;69(2):292-302 - PubMed
  29. Mult Scler. 2013 Dec;19(14):1887-95 - PubMed
  30. Brain. 2016 Jan;139(Pt 1):39-46 - PubMed
  31. Neurology. 2017 Jun 13;88(24):2294-2301 - PubMed
  32. Ann Intern Med. 2007 Oct 16;147(8):573-7 - PubMed
  33. Neurology. 1983 Nov;33(11):1444-52 - PubMed
  34. Ann Neurol. 2009 Sep;66(3):310-22 - PubMed
  35. Diabetes Care. 2013 Sep;36(9):2748-55 - PubMed
  36. Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2498-504 - PubMed
  37. Optom Vis Sci. 2012 May;89(5):812-7 - PubMed
  38. Lancet Neurol. 2008 Jul;7(7):615-25 - PubMed
  39. J Neurol Sci. 2009 Jun 15;281(1-2):74-9 - PubMed
  40. Diabetologia. 2018 Aug;61(8):1856-1861 - PubMed
  41. Parkinsonism Relat Disord. 2015 Dec;21(12):1454-60 - PubMed
  42. J Clin Neurosci. 2017 May;39:53-58 - PubMed
  43. Am J Pathol. 2014 Jun;184(6):1652-9 - PubMed
  44. Ann Clin Transl Neurol. 2019 Jan 19;6(2):222-232 - PubMed
  45. Invest Ophthalmol Vis Sci. 2014 Apr 03;55(4):2071-8 - PubMed
  46. Curr Eye Res. 2021 Oct;46(10):1452-1459 - PubMed
  47. Cornea. 2013 May;32(5):e83-9 - PubMed

Publication Types

Grant support